Pınar Kubilay Tolunay - Search Results

Year	Number of Results
2022	1
2024	4
2025	6

1

A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy.

Öner İ, Anık H, Kurt İnci B, Kubilay Tolunay P, Ateş Ö, Yalçıntaş Arslan Ü, Karaçin C. Öner İ, et al. Among authors: kubilay tolunay p. Medicina (Kaunas). 2025 Feb 19;61(2):360. doi: 10.3390/medicina61020360. Medicina (Kaunas). 2025. PMID: 40005476 Free PMC article.

2

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer.

Gürbüz M, Doğan İ, Akkuş E, Özakıncı H, Kubilay Tolunay P, Kalacı E, Bağlan T, Köksoy EB, Ceyhan K, Dizbay Sak S, Aydıner A, Demirkazık A, Utkan G. Gürbüz M, et al. Among authors: kubilay tolunay p. Tuberk Toraks. 2022 Jun;70(2):132-140. doi: 10.5578/tt.20229803. Tuberk Toraks. 2022. PMID: 35785877 Free article. English.

3

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.

Kurt İnci B, Kubilay Tolunay P, Öztekin Ş, Aydemir E, Öner İ, Ateş Ö, Karaçin C. Kurt İnci B, et al. Among authors: kubilay tolunay p. Curr Oncol. 2024 Sep 24;31(10):5722-5729. doi: 10.3390/curroncol31100424. Curr Oncol. 2024. PMID: 39451728 Free PMC article.

4

Understanding of Clinical Trials Among Patients With Cancer and Their Relatives.

Kubilay Tolunay P, Erol C, Kahraman S, Yildiz Tacar S, Özcan E, Bugdayci Basal F, Köse F, Sendur MAN, Tural D, Çiçin I, Öksüzoglu B, Kiliçkap S, Ürün Y. Kubilay Tolunay P, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2457020. doi: 10.1001/jamanetworkopen.2024.57020. JAMA Netw Open. 2025. PMID: 39874033 Free PMC article.

5

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Yılmaz F, Yaşar S, Mandel NM, Kaçan T, Özdemir M, Doğu GG, Şengül N, Meydan N, Başal FB, Tolunay PK, Hamamcı MB, Dinçer OS, Bahçeci A, Özer L, Ajredini M, Kırca Ö, Yersal Ö, Can O, Günaldı M, Demir G, Yalçın Ş. Yılmaz F, et al. Among authors: tolunay pk. Target Oncol. 2024 Nov;19(6):957-964. doi: 10.1007/s11523-024-01095-4. Epub 2024 Sep 25. Target Oncol. 2024. PMID: 39317891

6

Timing of Dose Reductions and Survival Outcomes in Metastatic Breast Cancer Patients Treated with Cyclin-Dependent Kinase 4/6 Inhibitors.

Kubilay Tolunay P, Kurt İnci B, Usta Ş, Topkaç A, Karabuğa B, Aydemir E, Öner İ, Akay Hacan B, Ateş Ö, Karaçin C, Yalçıntaş Arslan Ü. Kubilay Tolunay P, et al. Curr Oncol. 2024 Nov 22;31(12):7426-7436. doi: 10.3390/curroncol31120548. Curr Oncol. 2024. PMID: 39727671 Free PMC article.

7

Impact of the CPS-EG score as a new prognostic biomarker in triple-negative breast cancer patients who received neoadjuvant chemotherapy.

Öner İ, Türkel A, İnci BK, Tolunay PK, Ateş Ö, Karaçin C. Öner İ, et al. Among authors: tolunay pk. BMC Cancer. 2024 Oct 30;24(1):1338. doi: 10.1186/s12885-024-13100-0. BMC Cancer. 2024. PMID: 39478493 Free PMC article.

8

Comparison of AI chatbot predicted and realworld survival outcomes in hepatocellular carcinoma.

Kavak EE, Erdat EC, Altundağ Derin Z, Dilli İ, Kubilay Tolunay P, Öksüzoğlu B, Akbulut H. Kavak EE, et al. Among authors: kubilay tolunay p. Sci Rep. 2025 Jul 1;15(1):21728. doi: 10.1038/s41598-025-06591-9. Sci Rep. 2025. PMID: 40596129 Free PMC article.

9

Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.

Baş O, İnci BK, Eroğlu İ, Efil SC, Kaya S, Tolunay PK, Şahin TK, Karaçin C, Yazıcı O, Şendur MAN, Öksüzoğlu BÖÇ, Aksoy S. Baş O, et al. Among authors: tolunay pk. BMC Cancer. 2025 Nov 28;25(1):1831. doi: 10.1186/s12885-025-15181-x. BMC Cancer. 2025. PMID: 41316060 Free PMC article.

10

Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort.

Erul E, Öksüz NE, Akkus E, Tolunay PK, Köksoy EB, Yasar HA. Erul E, et al. Among authors: tolunay pk. Medicina (Kaunas). 2025 Oct 31;61(11):1960. doi: 10.3390/medicina61111960. Medicina (Kaunas). 2025. PMID: 41303797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year